Literature DB >> 14709491

Variations in neurodegenerative disease across the UK: findings from the national study of Progressive Intellectual and Neurological Deterioration (PIND).

G Devereux1, L Stellitano, C M Verity, A Nicoll, R G Will, P Rogers.   

Abstract

AIMS: To identify any UK children with variant Creutzfeldt-Jakob disease (vCJD) and obtain information about the causes of progressive intellectual and neurological deterioration (PIND) and the geographical distribution of cases.
METHODS: The PIND Study uses the monthly surveillance card that is sent to all UK paediatricians by the British Paediatric Surveillance Unit. Case details are obtained from the reporting paediatricians by telephone interview, site visit, or self completion of a questionnaire. A paediatric neurology expert group then classifies the anonymised cases. The Communicable Disease Surveillance Centre (CDSC) provides mapping support.
RESULTS: After five years and five months of surveillance, 1400 children had been reported. In the UK the majority of PIND cases had a confirmed diagnosis (comprising 99 different conditions); 505 "no cases" and 97 "outstanding" cases were excluded. A total of 798 PIND cases were included as follows: 577 with a confirmed underlying diagnosis; six with definite or probable vCJD, 51 who had undiagnosed PIND but were not thought to have vCJD, and 164 cases who were still under investigation. In some districts there were unexpectedly high numbers of PIND cases with a heterogeneous mixture of underlying diagnoses. In the five districts with the largest numbers of resident cases the majority not only came from a particular ethnic group but also had high reported rates of consanguinity.
CONCLUSIONS: In districts with large numbers of PIND cases there are major resource implications. These children and their families have complex problems and they need access to diagnostic facilities and appropriate service provision.

Entities:  

Mesh:

Year:  2004        PMID: 14709491      PMCID: PMC1755902     

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  14 in total

1.  Supporting children with serious health care needs. Analyzing the costs and benefits.

Authors:  G Roberts
Journal:  Eval Health Prof       Date:  2001-03       Impact factor: 2.651

Review 2.  Surveillance for rare disorders by the BPSU. The British Paediatric Surveillance Unit.

Authors:  C Verity; M Preece
Journal:  Arch Dis Child       Date:  2002-10       Impact factor: 3.791

Review 3.  Public health surveillance: historical origins, methods and evaluation.

Authors:  S Declich; A O Carter
Journal:  Bull World Health Organ       Date:  1994       Impact factor: 9.408

4.  A five-year prospective study of the health of children in different ethnic groups, with particular reference to the effect of inbreeding.

Authors:  S Bundey; H Alam
Journal:  Eur J Hum Genet       Date:  1993       Impact factor: 4.246

5.  The doctor's dilemma: challenges for the primary care physician caring for the child with special health care needs.

Authors:  Emily J Davidson; Thomas J Silva; Lisa A Sofis; Michael L Ganz; Judith S Palfrey
Journal:  Ambul Pediatr       Date:  2002 May-Jun

6.  Variant Creutzfeldt-Jakob disease in UK children: a national surveillance study.

Authors:  C M Verity; A Nicoll; R G Will; G Devereux; L Stellitano
Journal:  Lancet       Date:  2000-10-07       Impact factor: 79.321

7.  Disability in children from different ethnic populations.

Authors:  R Morton; V Sharma; J Nicholson; M Broderick; J Poyser
Journal:  Child Care Health Dev       Date:  2002-01       Impact factor: 2.508

Review 8.  Ethical dimensions of genetics in pediatric neurology: a look into the future.

Authors:  Denise M Avard; Bartha M Knoppers
Journal:  Semin Pediatr Neurol       Date:  2002-03       Impact factor: 1.636

9.  Medical and nursing problems of children with neurodegenerative disease.

Authors:  A Hunt; R Burne
Journal:  Palliat Med       Date:  1995-01       Impact factor: 4.762

10.  A comparison of disease and gene frequencies of inborn errors of metabolism among different ethnic groups in the West Midlands, UK.

Authors:  A C Hutchesson; S Bundey; M A Preece; S K Hall; A Green
Journal:  J Med Genet       Date:  1998-05       Impact factor: 6.318

View more
  6 in total

1.  Beyond counting cases: public health impacts of national Paediatric Surveillance Units.

Authors:  D Grenier; E J Elliott; Y Zurynski; R Rodrigues Pereira; M Preece; R Lynn; R von Kries; H Zimmermann; N P Dickson; D Virella
Journal:  Arch Dis Child       Date:  2006-12-11       Impact factor: 3.791

2.  Population stratification and genetic association studies in South Asia.

Authors:  Alan H Bittles
Journal:  J Mol Genet Med       Date:  2005-12-30

3.  A clinicopathological study of selected cognitive impairment cases in Lothian, Scotland: enhanced CJD surveillance in the 65 + population group.

Authors:  Lovney Kanguru; Gemma Logan; Briony Waddel; Colin Smith; Anna Molesworth; Richard Knight
Journal:  BMC Geriatr       Date:  2022-07-20       Impact factor: 4.070

4.  Born in Bradford, a cohort study of babies born in Bradford, and their parents: protocol for the recruitment phase.

Authors:  Pauline Raynor
Journal:  BMC Public Health       Date:  2008-09-23       Impact factor: 3.295

5.  'Why does it happen like this?' Consulting with users and providers prior to an evaluation of services for children with life limiting conditions and their families.

Authors:  Anne Hunt; Erica Brown; Jane Coad; Sophie Staniszewska; Suzanne Hacking; Brigit Chesworth; Lizzie Chambers
Journal:  J Child Health Care       Date:  2013-11-21       Impact factor: 1.979

6.  Surveillance for variant CJD: should more children with neurodegenerative diseases have autopsies?

Authors:  Christopher Verity; Anne Marie Winstone; Robert Will; Alison Powell; Peter Baxter; Carlos de Sousa; Paul Gissen; Manju Kurian; John Livingston; Robert McFarland; Suvankar Pal; Michael Pike; Richard Robinson; Evangeline Wassmer; Sameer Zuberi
Journal:  Arch Dis Child       Date:  2018-10-18       Impact factor: 3.791

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.